EN DE
Check 35,000+ stocks against 26 valuation models and 37 quality factors
Data-driven stock valuation

Centrale dAchat Française pour lOutre-Mer Société Anonyme (ALCGM) fair value: what the stock is really worth

As of Sep 22, 2026: fair value of Centrale dAchat Française pour lOutre-Mer Société Anonyme €15.02, price €11.00, upside +36.6%, quality 50 out of 100. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.

  1. Fair value above price? Yes
  2. Good quality? Yes
  3. Add to watchlist

Healthcare · ISIN FR0000053506

CD Some data Sep 23, 2026

Centrale dAchat Française pour lOutre-Mer Société Anonyme

ALCGM · PA

SpeculativeUpside exists, but weak quality makes the signal speculative.

✓Fair value €15.02 · Undervalued (+37%)
!Quality 50/100
!Mixed Growth (revenue 5y +5.5 %/yr)
!Thin margins · 1.5% net margin (TTM)
✓Moderate debt · generates free cash flow
✓Ranks above peers (10/14)
!Narrow moat 31/100
!Evidence only medium, so the estimate is less certain
!Weak on past: 12 out of 100
Watch Centrale dAchat Française pour lOutre-Mer Société Anonyme for free, get notified when fair value or trend changes. Plus fair value for all 35,000+ stocks, 14 days of Pro free, no card. Watch for free Pro now: $1 first month

What runs behind every stock

69 individual criteria per stock, every one traceable See the method →

Price vs Fair Value

€28.33 €8.90 Fair Value €15.02 Jul 2021 Sep 2026

White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Sep 23, 2026.

How to read this chart

60‑month range €8.90 – €28.33 · fair‑value band €13.65 – €18.78 · the €11.00 price screens below the €15.02 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). 3 fiscal years are left out: there the valuation rested on only a fraction of the usual models. Dashed = 300-day average. As of Sep 23, 2026.

Follow Centrale dAchat Française pour lOutre-Mer Société Anonyme in your weekly email

Every Wednesday you see whether Centrale dAchat Française pour lOutre-Mer Société Anonyme is on track or worth a review, plus price against fair value. Free, up to 3 stocks.

We send you a confirmation link. Unsubscribe with one click.

Which stocks are undervalued right now? Check free Discover now →

Company profile

Cegedim SA operates as a technology and services company in the field of digital data flow management for healthcare ecosystem and B2B in France, rest of Europe, and internationally. It operates through Health Insurance, HR and E-Services; Healthcare Professionals; and Cloud & Support segments.

Show more

Cegedim SA operates as a technology and services company in the field of digital data flow management for healthcare ecosystem and B2B in France, rest of Europe, and internationally. It operates through Health Insurance, HR and E-Services; Healthcare Professionals; and Cloud & Support segments. The Health Insurance, HR and E-Services segment markets various products and services to insurance companies, mutual insurers, personal protection insurers, and insurance brokers, as well as engages in the interactions between these entities and healthcare professionals. This segment also provides solutions for IT services and hosting, digitization, human resources and payroll management outsourcing, electronic data exchange, and data processing services. The Healthcare Professionals division sells management software, databases, and solutions to doctors, paramedical professionals, pharmacists, and healthcare facilities. It also operates as a business software publisher for healthcare and insurance professionals. The company was incorporated in 1969 and is headquartered in Boulogne-Billancourt, France. Cegedim SA is a subsidiary of FCB SAS.

Stock analysis

Centrale dAchat Française pour lOutre-Mer Société Anonyme (ALCGM) currently trades at €11.00, while our model-based Fair Value estimate is €15.02, implying the stock looks roughly 26.8% undervalued today.

Show more

Valuation

Bull case: the Growth DCF group reads highest at a median of €32.41 per share, and 20 of the 23 models we run sit above the €11.00 price.

Bear case: the Earnings-Based group reads lowest at €4.87, and 3 of the 23 models stay below the price. Evidence for this calculation is medium.

Scenario range: €13.65 (bear) to €18.78 (bull), the price of €11.00 sits below it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.

Quality & growth

The Quality Score stands at 50/100 (solid quality), in the Healthcare sector.

Mixed Growth: Revenue is growing, but margins or cash flow do not fully confirm the trend.

Centrale dAchat Française pour lOutre-Mer Société Anonyme reported revenue of €649M in FY2025 versus €525M in FY2021, a compound +5.5%/yr. Reported net income was €9.4M in FY2025, compounding −22.6%/yr from FY2021.

Key figures

Market cap €151M · P/E ratio 15.7 · P/S ratio 0.23 · EPS (TTM) €0.7000 · Net margin 1.4% · Return on equity 2.9% · Return on assets (EBIT) 2.9% · Operating margin 6.3%.

Competitive moat

Our AI-assisted moat analysis scores the competitive advantage at 43 out of 100 (low confidence).

What moves the price

The share trades about 23% below its 52-week high and 24% above its 52-week low, currently below its 200-day average.

For context, the median of 10 Healthcare peers we cover trades at −45% fair-value upside, at 37%, ALCGM screens cheaper than that median.

Fair Value models

Bear €13.65 Fair Value €15.02 Bull €18.78
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above is their evidence-weighted blend, not the output of a single model. Based on fiscal year 2025 figures (about 9 months old). Earnings retained since then (€0.5140 per share) are deliberately not added. Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. Evidence ⓘEvidence = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Highest evidence
FCF DCF €36.42 €50.90 €67.89 81
Growth DCF €36.86 €49.79 €64.26 80
Owner Earnings €10.81 €17.19 €24.67 76
All 23 models by family
DCF Models
FCF DCF €36.42 €50.90 €67.89 81
Owner Earnings €10.81 €17.19 €24.67 76
5Y Revenue Exit €21.50 €31.49 €43.26 73
5Y EBITDA Exit €58.37 €97.57 €141.67 74
5Y P/E Exit €16.61 €22.74 €28.52 72
10Y Revenue Exit €27.49 €36.95 €47.93 68
10Y EBITDA Exit €47.71 €75.28 €109.61 68
10Y P/E Exit €25.30 €31.87 €38.68 65
Earnings-Based
Graham-Dodd €4.64 €11.58 €15.02 65
PEG = 1.0 €2.11 €3.02 €3.92 57
EPV €3.35 €4.87 €6.11 73
Multiples
P/E Multiple €11.27 €15.02 €18.78 63
P/S Multiple €8.71 €11.61 €14.51 58
P/B Multiple €8.71 €11.61 €14.51 55
EV/EBIT €18.67 €28.01 €37.35 65
EV/EBITDA €88.77 €121.47 €154.17 67
EV/Revenue €10.65 €19.22 €27.79 52
Asset-Based
NCAV (Graham) €10.25 €13.74 €20.50 54
Growth DCF
Growth DCF €36.86 €49.79 €64.26 80
Rev-Margin DCF €21.50 €32.41 €44.62 73
Economic Profit
Residual Income €13.45 €12.60 €9.43 76
ROIC Compounder €3.35 €4.87 €6.11 72
Growth Earnings
Growth-Adj P/E €8.64 €12.35 €16.05 67

Open the full fair value analysis →

Notify me when ALCGM reaches fair value

Put ALCGM on your watchlist. We get in touch as soon as price and fair value meet or the trend turns.

Set up alert →

Quality Score breakdown

Overall quality 50/100

Of which business quality 49 · Market factors (momentum, volatility) 51

Profitability 27
Margins and returns on capital today
Quality Growth 38
Are margins and returns improving?
Cashflow 66
Earnings quality: real cash, not paper profit
Fin. Strength 30
Balance sheet, leverage, solvency risk
Investment 76
Disciplined investing over empire-building
Low Volatility 71
Calm price path (market factor)
Momentum 45
Price trend over the last 3–12 months (market factor)
52W Momentum 40
Distance to the 52-week high (market factor)
Net Issuance 78
Share count: buybacks or dilution?

Open the full quality analysis →

Revenue & earnings trend

Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card. 56/100
Revenue is growing, but margins or cash flow do not fully confirm the trend.
Revenue growth 1 year
−0.8%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+5.4%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+5.5%
Start year 2020 (pandemic). Over 10 years: +4.3% a year
Revenue growth 23 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+2.9%
What shareholders gained per year (last 5 years) ⓘWhat the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 5 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate.
−2.7%
Earnings growth per share plus dividend.
Earnings per share, growth per year−2.7%
Dividend (yield on the price)0.0%
Pace: 5 vs 10 years ⓘTwo data points, not a trend model: earnings growth per share over the last 5 fiscal years against the last 10. Labelled "steady" when both rates are within 3 percentage points of each other, otherwise picking up or flattening. Shown only when ten years of history exist.−3% vs −18%, picking up
Profit margin 2020 to 2025 ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.4% → 5%
Start year 2020 (pandemic)

Watch ALCGM, get fair value alerts →

Compare Centrale dAchat Française pour lOutre-Mer Société Anonyme with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Health Information Services · 134 stocks

Beats the industry median on 9/13 measures
Overall it ranks above its industry peers.
Valuation
Quality Score 50 · Below median
Fair Value upside +37% · Top 25%
Profitability
Return on equity (TTM) 3% · Above median
Return on assets 2% · Above median
Net margin (TTM) 1% · Below median
Operating margin (TTM) 6% · Above median
Growth and dividend
Revenue growth −3% · Below median
Balance sheet
Debt / equity 0.78× · Highest 25%

Valuation Multiplesvs Health Information Services median · lower = cheaper

P/E (TTM) 15.7× · Cheapest 25%
P/B 0.61× · book value is mostly goodwill ⓘGoodwill and other intangible assets are larger than the equity. The book value mainly reflects prices paid for past acquisitions, so we do not rank this P/B against the peer group.
P/S (TTM) 0.27× · Cheapest 25%
P/FCF 2.2× · Cheapest 25%
EV/EBITDA 5.3× · Cheapest 25%
PEG 0.67× · Cheapest 25%

Strength profile in five axes (Snowflake)

VALUEFUTUREPASTHEALTHDIVIDEND
This stock
VALUEFUTUREPASTHEALTHDIVIDEND
Sector peers
VALUE (fair-value potential)82 · sector 3
FUTURE (revenue growth)0 · sector 34
PAST (return on equity)12 · sector 5
HEALTH (low debt)61 · sector 98
DIVIDEND (yield)0 · sector 48

Context: sector, industry, market

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

Similar stocks

10 more Health Information Services stocks, each showing price versus our Fair Value estimate.

Stock Price Fair Value vs Fair Value
Veeva Systems Inc VEEV $260.91 $287.00 +10%
Pro Medicus Limited PME A$161.31 A$64.50 −60%
BrightSpring Health Services, Inc BTSG $56.55 $26.07 −54%
HealthEquity, Inc HQY $91.75 $100.93 +10%
Hinge Health, Inc HNGE $94.15 $51.66 −45%
10x Genomics, Inc TXG $80.70 $21.71 −73%
Waystar Holding WAY $25.63 $28.19 +10%
XtalPi Holdings 2228 HK$8.39 HK$1.50 −82%
Doximity, Inc DOCS $26.51 $31.41 +18%
Privia Health Group PRVA $19.46 $5.26 −73%

Explore undervalued stocks

More undervalued Healthcare stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued High-Quality StocksUndervalued Blue-Chip StocksUndervalued Small-Cap StocksUndervalued Dividend Stocks

Try a ready-made strategy

Pick a strategy and jump into the live analysis with that exact screen applied.

🥇 Backtested Best 🏆 Big Names ⭐ Top Rated 💎 Quality on Sale 🚀 Profitable Growth 🧊 Quality Compounders 💵 Dividend Stars 📈 Strong Momentum 📉 Fallen Angels ⚖️ Deeply Undervalued 🔍 Small-Cap Gems 🏰 Moat at a Fair Price 💼 Insider Buying 🎩 Buffett-Style Quality 📚 Peter Lynch GARP 🧮 Greenblatt Magic Formula 🛡️ Graham Defensive

Discover tools

For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Cite: Fair Value Calculator (2026). "Centrale dAchat Française pour lOutre-Mer Société Anonyme Fair Value". https://www.fairvalue-calculator.com/stock/ALCGM

Frequently asked questions

Is Centrale dAchat Française pour lOutre-Mer Société Anonyme (ALCGM) overvalued or undervalued?
As of Sep 23, 2026, our model estimates a fair value of €15.02 versus a price of €11.00, about +37% upside (undervalued).
What is the fair value of ALCGM?
Our model-based fair value for Centrale dAchat Française pour lOutre-Mer Société Anonyme is €15.02 (as of Sep 23, 2026), built from audited fundamentals. The current price: €11.00.
What is the quality score of ALCGM?
Centrale dAchat Française pour lOutre-Mer Société Anonyme has a Quality Score of 50/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Centrale dAchat Française pour lOutre-Mer Société Anonyme (ALCGM)?
Our model-based price target is the fair value of €15.02 (as of Sep 23, 2026) from 23 valuation models. Cautious scenario €13.65, optimistic scenario €18.78. It is a calculation from audited fundamentals, not an analyst target.
What is the Centrale dAchat Française pour lOutre-Mer Société Anonyme stock forecast for 2026?
Our models put fair value at €15.02, about +37% upside versus a price of €11.00 (undervalued). Cautious scenario €13.65, optimistic scenario €18.78. The calculation is refreshed regularly with new filings.
What is the revenue of Centrale dAchat Française pour lOutre-Mer Société Anonyme (ALCGM)?
Centrale dAchat Française pour lOutre-Mer Société Anonyme reported trailing-twelve-month revenue of about €649M (latest available figure, as of Sep 23, 2026).
What is the intrinsic value of Centrale dAchat Française pour lOutre-Mer Société Anonyme (ALCGM)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Centrale dAchat Française pour lOutre-Mer Société Anonyme it is €15.02 per share (as of Sep 23, 2026), against a price of €11.00. It is the blended result of 23 valuation models (cash flow, earnings, asset, dividend).
Is Centrale dAchat Française pour lOutre-Mer Société Anonyme stock overvalued or undervalued in 2026?
As of Sep 23, 2026, ALCGM trades below its calculated fair value: price €11.00, fair value €15.02, a gap of about +37% (undervalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of ALCGM?
No. The price is what the market pays today (€11.00); the fair value is what the company's own numbers justify (€15.02). For Centrale dAchat Française pour lOutre-Mer Société Anonyme the two are €4.02 per share apart. That gap is exactly why we show both numbers side by side.
How much is Centrale dAchat Française pour lOutre-Mer Société Anonyme worth?
The market values Centrale dAchat Française pour lOutre-Mer Société Anonyme at about €151M (market capitalisation, as of Sep 23, 2026). Per share that is €11.00; our models calculate a fair value of €15.02 per share.
What do the bullish and bearish scenarios say about ALCGM?
Our models span a range for Centrale dAchat Française pour lOutre-Mer Société Anonyme: cautious scenario €13.65, base €15.02, optimistic €18.78 per share (as of Sep 23, 2026, price €11.00). The range comes from different growth and margin assumptions, not from analyst opinions.
What is the P/E ratio of ALCGM?
Centrale dAchat Française pour lOutre-Mer Société Anonyme trades at a price-to-earnings ratio of 15.7 (as of Sep 23, 2026). A P/E on its own says little: it compares the price with ONE year of profit, while our fair value of €15.02 is built from several models across several years. Other multiples: PEG 0.7, P/B 0.6, P/S 0.3, EV/EBITDA 5.3.
What is the PEG ratio of ALCGM?
The PEG ratio of Centrale dAchat Française pour lOutre-Mer Société Anonyme is 0.67 (P/E divided by earnings growth, as of Sep 23, 2026). That is below 1, so growth is priced more cheaply than the earnings multiple alone suggests.
How solid is the balance sheet of Centrale dAchat Française pour lOutre-Mer Société Anonyme (ALCGM)?
Balance-sheet figures for Centrale dAchat Française pour lOutre-Mer Société Anonyme (as of Sep 23, 2026): return on equity 2.9%, debt of 0.78 per unit of equity. They feed the Quality Score of 50/100, which measures business quality independently of the share price.
How far is ALCGM from its 52-week high?
Centrale dAchat Française pour lOutre-Mer Société Anonyme trades at €11.00, about 23% below its 52-week high of €14.35 and 24% above the low of €8.90 (as of Sep 22, 2026). Distance from the high says nothing about value: that is what the fair value of €15.02 is for.
Which stocks are comparable to Centrale dAchat Française pour lOutre-Mer Société Anonyme?
From the same area (Healthcare) we also value Veeva Systems Inc, Pro Medicus Limited, BrightSpring Health Services, Inc, HealthEquity, Inc, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Centrale dAchat Française pour lOutre-Mer Société Anonyme stock attractive at the current price?
The data as of Sep 23, 2026: price €11.00, calculated fair value €15.02 (+37%), Quality Score 50/100, from 23 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of ALCGM calculated?
We run Centrale dAchat Française pour lOutre-Mer Société Anonyme through 23 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of €15.02, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 13.2 % above its aggregate fair value. Centrale dAchat Française pour lOutre-Mer Société Anonyme currently trades 37 % below its own fair value, and the market average says nothing about that. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Centrale dAchat Française pour lOutre-Mer Société Anonyme (ALCGM)?
The closing price on Sep 22, 2026 was €11.00. Our model-based fair value is €15.02, about +37% upside (undervalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Centrale dAchat Française pour lOutre-Mer Société Anonyme right now?
The price is below even our cautious bear case (€13.65). The market is more pessimistic than our downside scenario. Solid quality (50/100) at a price below fair value, the discount is the argument here, not the business quality.

Key figures of Centrale dAchat Française pour lOutre-Mer Société Anonyme

How large is the market capitalisation of Centrale dAchat Française pour lOutre-Mer Société Anonyme (ALCGM)?
The market capitalisation of Centrale dAchat Française pour lOutre-Mer Société Anonyme is €151M. The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Centrale dAchat Française pour lOutre-Mer Société Anonyme (ALCGM)?
The price-to-sales ratio of Centrale dAchat Française pour lOutre-Mer Société Anonyme is 0.23 (P/E × margin). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Centrale dAchat Française pour lOutre-Mer Société Anonyme (ALCGM)?
Earnings per share at Centrale dAchat Française pour lOutre-Mer Société Anonyme are €0.7000 (price ÷ EPS = P/E 15.7). Earnings per share over the last twelve months: total profit spread across every single share.
What is the net margin of Centrale dAchat Française pour lOutre-Mer Société Anonyme (ALCGM)?
The net margin of Centrale dAchat Française pour lOutre-Mer Société Anonyme is 1.4% (fiscal year 2025). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Centrale dAchat Française pour lOutre-Mer Société Anonyme (ALCGM)?
The return on equity (ROE) of Centrale dAchat Française pour lOutre-Mer Société Anonyme is 2.9% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Centrale dAchat Française pour lOutre-Mer Société Anonyme (ALCGM)?
On an EBIT basis the return on assets of Centrale dAchat Française pour lOutre-Mer Société Anonyme is 2.9% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Centrale dAchat Française pour lOutre-Mer Société Anonyme (ALCGM)?
The operating margin of Centrale dAchat Française pour lOutre-Mer Société Anonyme is 6.3% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Centrale dAchat Française pour lOutre-Mer Société Anonyme (ALCGM)?
Revenue at Centrale dAchat Française pour lOutre-Mer Société Anonyme is growing −2.6% versus a year earlier (3y avg +5.4%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at Centrale dAchat Française pour lOutre-Mer Société Anonyme (ALCGM)?
Earnings per share at Centrale dAchat Française pour lOutre-Mer Société Anonyme are growing +87.0% versus a year earlier. How much earnings per share grew versus a year earlier.
How much free cash flow does Centrale dAchat Française pour lOutre-Mer Société Anonyme (ALCGM) generate?
The free cash flow of Centrale dAchat Française pour lOutre-Mer Société Anonyme is €78.3M (fiscal year 2025). The cash truly left after running and investing in the business, this is what pays dividends and buybacks.
How much net debt does Centrale dAchat Française pour lOutre-Mer Société Anonyme (ALCGM) carry?
The net debt of Centrale dAchat Française pour lOutre-Mer Société Anonyme is €276M (fiscal year 2024, ≈ 3.5 yrs of FCF). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed

Watch Centrale dAchat Française pour lOutre-Mer Société Anonyme in the live analysis

One click puts Centrale dAchat Française pour lOutre-Mer Société Anonyme on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.

Watch for free →

Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.